CymaBay Therapeutic (CBAY) PT Raised to $28 at H.C. Wainwright
Tweet
Share
E-mailGet Alerts CBAY Hot Sheet
Price: $32.48 --0%
Rating Summary:
7 Buy, 11 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 12 | Down: 21 | New: 20
Rating Summary:
7 Buy, 11 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 12 | Down: 21 | New: 20
Join SI Premium – FREE
H.C. Wainwright analyst Ed Arce raised the price target on CymaBay Therapeutic (NASDAQ: CBAY) to $28.00 (from $24.00) while maintaining a Buy rating.
You May Also Be Interested In
- Freedom Broker Upgrades PrimeEnergy Resource (PNRG) to Hold
- Candel Therapeutics Inc. (CADL) PT Raised to $15 at Freedom Broker
- Alkem Laboratories Ltd (ALKEM:IN) PT Lowered to INR6,850 at Nomura/Instinet
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
